BSV has developed
considerable market strengths in the domestic markets
through its portfolio of niche primary line, life saving
injectables. The Company remains focused on ascending
the value chain in the manufacturing and marketing of
biological, pharmaceutical and biotechnology products
and is committed to enhancing the sales of these products.
The Company has in its portfolio
over 25 brands, most of them having the potential of
being a product capable of being marketed in the global
market. Exports would continue to propel the Company's
growth in the coming years.